IL33 and pancreatic neoplasm: By inhibiting Il33 expression, pitavastatin blocks the cytokine and nuclear functions of IL-33 in chronic inflammation, effectively reducing the risk of chronic pancreatitis and pancreatic cancer in mice and humans.